Welcome to Nanologica’s investor relations section.
Our ambition is to update shareholders as well as the capital market about Nanologica’s status and progress regularly. This is done via press releases, financial reports, video comments and presentations at different life science, biotech and investment events. Due to Nanologica’s large presence in the Swedish market, some material in this section is only available in Swedish. If you have any questions, kindly contact us at email@example.com.
To subscribe to our press releases and financial reports, please enter your e-mail address in the box below. You will then receive an e-mail where you need to confirm your subscription.